Literature DB >> 18279127

Trends in coronary artery bypass graft surgery in Victoria, 2001-2006: findings from the Australasian Society of Cardiac and Thoracic Surgeons database project.

Diem T Dinh1, Geraldine A Lee, Baki Billah, Julian A Smith, Gilbert C Shardey, Christopher M Reid.   

Abstract

OBJECTIVE: To examine trends in preoperative clinical characteristics, risk profiles and postoperative outcomes of patients undergoing isolated coronary artery bypass graft (CABG) surgery in Victoria. DESIGN, SETTING AND PATIENTS: A prospective analysis of 9372 patients undergoing isolated CABG surgery between 1 July 2001 and 30 June 2006 in six Victorian public hospitals, using the Australasian Society of Cardiac and Thoracic Surgeons database. MAIN OUTCOME MEASURES: Trends in patient baseline characteristics and risk factors, postoperative morbidity and 30-day mortality rate.
RESULTS: Over the 5 years, the mean age of patients undergoing isolated CABG surgery increased, from 65.4 years in 2001-02 to 66.0 years in 2005-06 (P < 0.001). There was also an increase in the proportion of patients with hypertension (70.2% to 75.8%; P < 0.001), respiratory disease (83.2% to 89.5%; P < 0.001) and left main coronary artery disease (22.1% to 26.1%; P = 0.03), while the number of patients undergoing repeat CABG surgery decreased (4.4% to 2.6%; P = 0.002). The overall 30-day mortality rate remained unchanged (2.2% to 1.8%; P = 0.983). Rates of other major postoperative complications showed no significant change over the study period.
CONCLUSION: Rates of 30-day mortality and postoperative morbidity after CABG surgery have remained steady, despite the surgical population being older. Short-term outcomes after CABG surgery in Victoria remain among the most favourable reported in any population undergoing this surgery.

Entities:  

Mesh:

Year:  2008        PMID: 18279127     DOI: 10.5694/j.1326-5377.2008.tb01587.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  7 in total

1.  Microbubble generation and transmission of medtronic's affinity hardshell venous reservoir and collapsible venous reservoir bag: an in-vitro comparison.

Authors:  Kieron C Potger; Darryl McMillan; Mark Ambrose
Journal:  J Extra Corpor Technol       Date:  2011-09

2.  Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.

Authors:  Colin R Lenihan; Maria E Montez-Rath; Christina T Mora Mangano; Glenn M Chertow; Wolfgang C Winkelmayer
Journal:  Ann Thorac Surg       Date:  2012-12-25       Impact factor: 4.330

3.  Trends in postcoronary artery bypass graft sternal wound dehiscence in a provincial population.

Authors:  Christopher Doherty; Duncan Nickerson; Danielle A Southern; Teresa Kieser; Jehangir Appoo; Jeffery Dawes; Michael A De Souza; Alan R Harrop; Doreen Rabi
Journal:  Plast Surg (Oakv)       Date:  2014       Impact factor: 0.947

4.  Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery.

Authors:  Akshat Saxena; Diem Dinh; Jim Dimitriou; Christopher Reid; Julian Smith; Gilbert Shardey; Andrew Newcomb
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-03

5.  Prophylactic intraaortic balloon counterpulsation in high-risk cardiac surgery: a survey of opinion and current practice.

Authors:  E Litton; A Delaney
Journal:  HSR Proc Intensive Care Cardiovasc Anesth       Date:  2013

6.  Epidemiology of coronary artery bypass grafting at the Hospital Beneficência Portuguesa, São Paulo.

Authors:  Alexandre Gonçalves de Sousa; Maria Zenaide Soares Fichino; Gilmara Silveira da Silva; Flávia Cortez Colosimo Bastos; Raquel Ferrari Piotto
Journal:  Rev Bras Cir Cardiovasc       Date:  2015 Jan-Mar

7.  Evolving mortality rates in people who inject drugs: An Australian tertiary hospital observational study on infective endocarditis.

Authors:  Isa Khan; Elizabeth Brookes; John Santamaria; Daniel Crisafi; Andrew Wilson; Jonathan Darby; Andrew Newcomb
Journal:  PLoS One       Date:  2022-08-26       Impact factor: 3.752

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.